Resources

Patients more likely to reach A1c target at any given time during 26 weeks’ treatment with liraglutide compared with both sitagliptin and exenatide…. 

Medical community resists super intensive exercise-based weight-loss programs that shed pounds and reduce the risk for diabetes and other cardiovascular risk factors…. 

The remission rates of type 2 diabetes after laparoscopic adjustable gastric banding are influenced by the duration of disease, according to interim results from the APEX study…. 

Drugs aimed at halting the molecular destruction of beta cells are likely the next step in the quest to stop the progression of autoimmune type 1 diabetes….

The dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin (Tradjenta, Boehringer Ingelheim and Lilly) is associated with significant improvements in glycated hemoglobin (HbA1c) in black patients with type 2 diabetes…. 

  Patients with diabetes experience significantly higher rates of surgical and systemic complications, higher mortality and increased length of stay during hospitalization following 11 major elective procedures….

Gastric bypass results in greater loss of lean muscle mass…. 

Almost half of nonobese adult with poorly controlled diabetes have latent autoimmune diabetes that has been misdiagnosed as type 2 diabetes….

Two years of treatment with an investigational combination of phentermine plus topiramate (Qnexa, Vivus) resulted in improved cardiometabolic risk factors, in addition to weight loss….

Are low-carb strategies OK for the kidneys of obese individuals without kidney disease?…